Kratom Industry Offers Own Standards As Another Firm Warned About FDA Rules

Warning to contract manufacturer Avalon Packaging points out all but one of the problems that have dogged the kratom industry, including saying the herb's safety for its intended use should be proved to FDA before it is used in supplements and noting GMP problems, an area a kratom industry trade group discusses specifically in the standards program also published Nov. 20. While FDA also notes another problem kratom industry has wrestled with over past year, salmonella contamination, it doesn't allege Avalon's products are opioids.

Businessman looking through a magnifying glass to documents

In a case of unfortunate timing, the American Kratom Association published standards intended to convince FDA and consumers of the herb's safety the same day the agency published its latest warning to a kratom supplement manufacturer.

Adding irony to the coincidence, FDA's warning letter to Utah consumer health product contract manufacturer Avalon Packaging Inc. points out...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Regulation

More from Policy & Regulation